Summary of Study ST003051

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001900. The data can be accessed directly via it's Project DOI: 10.21228/M84729 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003051
Study TitleShotgun lipidomics of breast cancer endocrine therapy persisters
Study TypeLipidomics
Study SummaryDespite adjuvant endocrine therapy, the rate of ER+ breast cancer recurrence remains high. The metabolic state of cells that remain after endocrine therapy, specifically oxidative stress, is poorly understood. We demonstrate that endocrine-tolerant persister cells are oxidatively stressed after initiation of endocrine therapy. Furthermore, modulation of redox levels similarly modifies persister cell fitness. We find ferroptosis sensitivity and lipid peroxidation to be a dominant factor in the oxidative state, and persister cells are found to be sensitive to ferroptosis induction compared to parental cells. Persister cells exhibited an altered lipidome, with an increase in phospholipids having a predilection for peroxidation. We hypothesized that ferroptosis induction would be well-coordinated with endocrine therapy. Xenografts treated with a combination of fulvestrant and ferroptosis induction exhibited the greatest treatment effect, supporting the role of ferroptosis as a therapeutic strategy in ER+ breast cancer.
Institute
Dartmouth College
DepartmentMolecular and Systems Biology
LaboratoryTodd Miller Lab
Last NameMiller
First NameTodd
AddressHanover, NH
EmailTodd.W.Miller@Dartmouth.edu
Phone603-646-5507
Submit Date2024-01-17
Raw Data AvailableYes
Raw Data File Type(s)wiff
Analysis Type DetailLC-MS
Release Date2024-02-13
Release Version1
Todd Miller Todd Miller
https://dx.doi.org/10.21228/M84729
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001900
Project DOI:doi: 10.21228/M84729
Project Title:Oxidative stress of breast cancer endocrine therapy persisters
Project Type:MS
Project Summary:Investigation of the oxidative state of persisters tolerant to endocrine therapy of breast cancer, with a focus on mechanism and therapeutic targeting
Institute:University of Michigan
Department:MRC2
Last Name:Kachman
First Name:Maureen
Address:Ann Arbor, MI, USA
Email:mkachman@med.umich.edu
Phone:734-232-0842

Subject:

Subject ID:SU003166
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Hormone treatment
SA331404Plasma poolNo
SA331405T47D fulv_3No
SA331406T47D fulv_2No
SA331407T47D fulv_1No
SA331411Test poolpooled
SA331408T47D veh_3Yes
SA331409T47D veh_1Yes
SA331410T47D veh_2Yes
Showing results 1 to 8 of 8

Collection:

Collection ID:CO003159
Collection Summary:Cells were washed with 150 mM ammonium acetate and flash frozen, before storage at -80deg C.
Sample Type:Breast cancer cells

Treatment:

Treatment ID:TR003175
Treatment Summary:The ER+ breast cancer cell line was subject to 1 uM of the selective estrogen receptor degrader (SERD), fulvestrant, with vehicle control control. Cells were subjected to treatment for 7 days, before reseeding into 10 cm dishes at 3-5e6 cells/dish.

Sample Preparation:

Sampleprep ID:SP003172
Sampleprep Summary:Standard lipidomics protocol. See protocol file.
Sampleprep Protocol Filename:A004_Shotgun_Lipidomics.PDF

Combined analysis:

Analysis ID AN005002 AN005003
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Shimadzu LC-30 Shimadzu LC-30
Column Waters ACQUITY UPLC HSS T3 (50 x 2.1mm,1.8um) Waters ACQUITY UPLC HSS T3 (50 x 2.1mm,1.8um)
MS Type ESI ESI
MS instrument type Triple TOF Triple TOF
MS instrument name ABI Sciex 5600+ TripleTOF ABI Sciex 5600+ TripleTOF
Ion Mode POSITIVE NEGATIVE
Units counts counts

Chromatography:

Chromatography ID:CH003780
Chromatography Summary:Positive mode lipidomics LC-MSMS
Instrument Name:Shimadzu LC-30
Column Name:Waters ACQUITY UPLC HSS T3 (50 x 2.1mm,1.8um)
Column Temperature:55
Flow Gradient:(Time : Pump B%) (0.01 : 40) (10.00 : 98) (17.00 : 98) (17.10 : 40)
Flow Rate:0.4 ml/min
Solvent A:Acetonitrile / water (40:60, v/v) with 10 mM ammonium acetate
Solvent B:Acetonitrile / water / isopropanol (10 : 5 : 85 v/v) with 10 mM ammonium acetate
Chromatography Type:Reversed phase

MS:

MS ID:MS004742
Analysis ID:AN005002
Instrument Name:ABI Sciex 5600+ TripleTOF
Instrument Type:Triple TOF
MS Type:ESI
MS Comments:Acquisition of MS/MS spectra was controlled by data dependent acquisition (DDA) function of the Analyst TF software. Lipids are identified using LIPIDBLAST package. Quantification of lipids is done by Multiquant software (AB-SCIEX). Normalization of the data for different lipid classes is performed based on a set of internal standards.
Ion Mode:POSITIVE
Acquisition Parameters File:LIP_15min_MSMS_Jenny_new_20min_mass100-1200_Valve_Positive.txt
  
MS ID:MS004743
Analysis ID:AN005003
Instrument Name:ABI Sciex 5600+ TripleTOF
Instrument Type:Triple TOF
MS Type:ESI
MS Comments:Acquisition of MS/MS spectra was controlled by data dependent acquisition (DDA) function of the Analyst TF software. Lipids are identified using LIPIDBLAST package. Quantification of lipids is done by Multiquant software (AB-SCIEX). Normalization of the data for different lipid classes is performed based on a set of internal standards.
Ion Mode:NEGATIVE
Acquisition Parameters File:LIP_15min_MSMS_Jenny_New_20min_valve_Negative.txt
  logo